Senior insider sale
President and COO at CG ONCOLOGY, INC. — senior position signals high conviction
$14.97M
206.74K shares
What this filing means
BELLETE AMBAW plans to sell 206.74K shares of CG ONCOLOGY, INC. valued at approximately $14.97M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/29/2026ACC: 0001950047-26-007416
Officer· President and COO
Since Jan 2024
206.74K
Shares to sell
$14.97M
Approx. market value
4.30K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
7/29/2026
4.30KTotal acquired4.30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/29/2026 | Stock Option Exercise Cash | 4.30K | — |
| Total | 4.30K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
50K
Market value
$3.63M
7/28/2026
—Completed
Units to sell
50K
Market value
$3.63M
7/27/2026
—Completed
Units to sell
50K
Market value
$3.59M
7/23/2026
—Completed
Units to sell
52.44K
Market value
$3.82M
7/15/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.30K
Market value
$316.3K
7/29/2026
Total
Units
206.74K
Value
$14.97M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/28/2026 | 50K | $3.63M | — | Completed |
7/27/2026 | 50K | $3.63M | — | Completed |
7/23/2026 | 50K | $3.59M | — | Completed |
7/15/2026 | 52.44K | $3.82M | — | Completed |
| Planned — Approximate Date | ||||
7/29/2026 | 4.30K | $316.3K | NASDAQ | Planned |
| Total | 206.74K | $14.97M | ||